Visalytics
Visalytics
approved EB-2 (NIW)

Senior Associate, Research Scientist

Biotechnology · Nepal · 2025-02-26

Processing Time
57 days
Decision Date
2025-02-26
Location
Canada
This case is from a publicly available case study. Case studies tend to feature successful outcomes and may not reflect the full range of petition results.

Proposed Endeavor

The petitioner proposes to continue his work in biotechnology by developing therapeutic molecules through structure-based enzyme engineering. His research focuses on creating novel molecules with anticancer properties and finding new avenues to treat antibiotic-resistant bacterial infections.

Framework Evaluation

3 of 3 criteria met
1 Substantial Merit and National Importance Met

The endeavor addresses drug resistance and cancer, which are significant health threats to the United States.

2 Well-positioned to Advance Endeavor Met

The petitioner's publication record, citation count, and prior funding from Taiwan's Ministry of Science and Technology demonstrate his ability to succeed.

3 Waiver Benefit Met

The potential for the petitioner's work to save lives and reduce healthcare costs makes a waiver of the job offer requirement beneficial to the U.S.

Why This Petition Was Approved

The petition was approved based on the petitioner's record of 5 peer-reviewed journal articles and 38 citations. His work was supported by Taiwan’s Ministry of Science and Technology and met the Dhanasar criteria by demonstrating substantial merit and national importance in the fight against drug resistance and cancer.

Evidence

Evidence Types
Peer Reviewed Publications
Citations
Grants
Reference Letters Independent

Similar Cases

Scientist

Biotechnology · China

WeGreened EB-2 (NIW) approved
Florida 115 days 2025-03-03
The petitioner proposes to continue developing novel anticancer therapeutics derived from microorganisms using integrated applications of genome mining, biosynthetic engineering, and synthetic biology to identify novel pathways and enzymes that improve drug efficacy, scalability, and safety.
View Case

Associate Professor

Biotechnology · Sudan

WeGreened EB-2 (NIW) approved
22 days 2023-08-01
The petitioner proposes to utilize biotechnological research techniques paired with molecular, pharmacological, and microbiological methods to discover novel drugs for the treatment of non-communicable diseases such as cancer and Alzheimer’s disease. This work focuses on enhancing drug efficacy and efficiency to develop therapeutics that reverse symptoms and alleviate healthcare and economic burdens.
View Case

Professor

Biotechnology · Ethiopia

WeGreened EB-2 (NIW) approved
87 days 2025-01-13
The petitioner proposes to continue research integrating advanced computational techniques and artificial intelligence to decode complex biological mechanisms and identify new drug targets. This work focuses on streamlining drug discovery processes and improving treatment efficacy for complex diseases such as Acute Myeloid Leukemia (AML).
View Case

Scientist

Biotechnology · Sri Lanka

WeGreened EB-2 (NIW) approved
Ohio 3 days 2024-02-08
The petitioner proposes to continue research on developing new methodologies for engineering and characterizing novel proteins and antibodies. This work aims to further biomedical studies, the biotechnology industry, and healthcare by providing foundations for innovations in therapeutic treatments.
View Case

Frequently Asked Questions

A approved EB-2 NIW (I-140) petition means USCIS determined the petitioner met the eligibility requirements. For appealed cases, "sustained" means the appeal reversed a prior denial. The petitioner can proceed to the next step in the immigration process.

Browse More Cases

More approved cases More Biotechnology cases More cases from Nepal

Case data sourced from publicly available petition decisions and case studies. Decision date: 2025-02-26.

Browse all cases
View Original

At a Glance

Outcome approved
Processing 57 days
Criteria Met 3 / 3
Evidence Types 4

EB-2 (NIW) Case Data

Scraped Case Data

Total Cases 3,813
Success Rate 53.7%
Sustained 2,046
Dismissed 1,671

Related Pages

EB-2 (NIW) Overview EB-2 (NIW) in Nepal All EB-2 (NIW) Cases EB-2 (NIW) Dashboard Endeavor Search

Get Case Insights

Compare your profile against thousands of real petition outcomes. Join the waitlist for personalized analysis.

Join Waitlist